This is an interesting therapeutic vaccine, since it uses the
adenovirus as a carrier vector. But everything is wide open here, there should be some concern Re side effects due to the adenovirus component.
The main problem for all therapeutic vaccines remains the same here: There could be a strong response to the vaccine epitopes, but the actual patient epitopes will be frequently mutated, so the activated t cells have nothing to find.